GlucoTrack

GCTK · NASDAQ

$0.6511−$0.0336 (−4.91%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $0.6847

Latest news

Press releaseOct 14, 9:00 AM ETBusiness Wire
Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
Press releaseOct 1, 5:15 PM ETBusiness Wire
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
Press releaseSep 30, 9:00 AM ETBusiness Wire
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
Press releaseSep 25, 9:00 AM ETBusiness Wire
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
Press releaseSep 24, 8:45 AM ETBusiness Wire
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
Press releaseSep 23, 4:30 PM ETBusiness Wire
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
NewsSep 23, 9:07 AM ET
Lōkahi Therapeutics And Glucotrack Issue Update On LT-100 Program And ai² Asset Monetization Strategy
Press releaseSep 23, 9:00 AM ETBusiness Wire
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
Press releaseSep 18, 9:00 AM ETBusiness Wire
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
Press releaseSep 11, 8:00 AM ETBusiness Wire
Glucotrack Announces $11.5 Million Financing
Press releaseSep 8, 9:15 AM ETBusiness Wire
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions
Press releaseSep 2, 9:15 AM ETBusiness Wire
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
Press releaseAug 27, 8:00 AM ETBusiness Wire
Glucotrack, Inc. Announces Reverse Stock Split
Press releaseAug 25, 8:00 AM ETBusiness Wire
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100
Press releaseAug 21, 8:00 AM ETBusiness Wire
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia
NewsAug 17, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseAug 17, 8:00 AM ETBusiness Wire
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
Press releaseAug 5, 8:30 AM ETBusiness Wire
Glucotrack Announces $5.5 Million Financing
NewsAug 4, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsJul 31, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseJul 31, 8:00 AM ETBusiness Wire
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
Press releaseJul 31, 8:00 AM ETBusiness Wire
CORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
NewsJul 30, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsJul 30, 8:06 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsJul 30, 12:37 AM ETMohd Haider
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving?
Press releaseJul 29, 5:30 PM ETBusiness Wire
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
Press releaseJul 17, 8:05 AM ETGlobe Newswire
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
NewsJul 17, 3:13 AM ETMohd Haider
GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On
NewsJul 16, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseJul 16, 4:57 PM ETGlobe Newswire
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
NewsJul 16, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsJul 15, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsJul 14, 11:27 PM ETMohd Haider
Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session
Press releaseJul 14, 5:40 PM ETGlobe Newswire
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
Press releaseJul 8, 8:00 AM ETGlobe Newswire
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
NewsJun 25, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 26, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsSep 15, 12:03 PM ET
Reported September 12, 2025: Glucotrack, Issues $3.6M Unsecured Convertible Promissory Note To Investor For A Purchase Price Of $3M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications

Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn

Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14

Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™

Glucotrack, Inc. Announces Pricing of $3 Million Public Offering

Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform

Lōkahi Therapeutics And Glucotrack Issue Update On LT-100 Program And ai² Asset Monetization Strategy

Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities

Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent

Glucotrack Announces $11.5 Million Financing

Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions

Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business

Glucotrack, Inc. Announces Reverse Stock Split

Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100

Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia

12 Health Care Stocks Moving In Monday's Pre-Market Session

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

Glucotrack Announces $5.5 Million Financing

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline

CORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving?

Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On

12 Health Care Stocks Moving In Thursday's After-Market Session

UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Glucotrack (GCTK) Stock Is Trending Overnight — Here’s Why it Spiked Over 69% in After-Hours Session

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

Reported September 12, 2025: Glucotrack, Issues $3.6M Unsecured Convertible Promissory Note To Investor For A Purchase Price Of $3M